Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Blood Biomarker Could Help Predict Severe Crohn’s Disease, Enable Early Intervention

    Diagnostics World News | An international group of researchers has shown that a biomarker may help predict complicated Crohn’s disease and can be detected long before diagnosis.

    Jul 12, 2022
  • Novel ct-DNA Blood Test Safely Spares Colon Cancer Patients from Chemotherapy

    Diagnostics World News | Australian-American researchers showcase a new ct-DNA diagnostic blood test that reduces the need for adjuvant chemotherapy without increasing colon cancer recurrence rates.

    Jul 7, 2022
  • DNA Methylation Making Its Mark In Early Cancer Detection

    Diagnostics World News | The current status in the development of DNA methylation biomarkers is a topic of several liquid biopsy talks at the upcoming Next Generation Dx Summit.

    Jul 6, 2022
  • A Look Ahead at Pan-Cancer Testing: Big Unknowns, Great Debates, and Key Questions Facing the Future of the Field

    Diagnostics World News | In recent months, Diagnostics World has explored the realm of pan-cancer testing.  As research and development continue in efforts to build upon the progress made so far, there’s still plenty to be sorted out. Here we dig a bit deeper into some of the biggest lingering issues facing the future of this fledgling field.

    Jul 5, 2022
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76 (current)
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy